Royal Bank of Canada
CPXX

Royal Bank of Canada’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Royal Bank of Canada’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-8
Closed – – 6861
2015
Q1 		$0 Buy
+8
New +$22 ﹤0.01% 6624

Other funds holding CPXX

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
NCCM
Nine Chapters Capital Management Short Hills, New Jersey $45.4M AUM 14.43% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RCM
Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 28.54% 1-Year Est. Return

Royal Bank of Canada's CPXX Position: Q2 2015 in Review

Royal Bank of Canada sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q2 2015, closing a stake of 8 shares.

Royal Bank of Canada first reported a position in CPXX in Q1 2015 and held it in 1 quarter. The position peaked at $0 in Q1 2015. 16 funds tracked by Wall St. Rank hold CPXX as of Q2 2015.

  • Royal Bank of Canada reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q2 2015 after selling out during the quarter.
  • Royal Bank of Canada sold 8 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q2 2015.
  • Royal Bank of Canada first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q1 2015 and held it in 1 quarter.
  • Royal Bank of Canada's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $0 in Q1 2015.
  • 16 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q2 2015.

Based on Royal Bank of Canada's 13F filing for Q2 2015, filed 14 Aug 2015.